Study shows arterial stiffness as a novel cause of premature heart damage among adolescents

Arterial stiffness is a novel cause of premature heart damage among adolescents, according to a new follow-up study.

Merck notches 38th approval for Keytruda, seventh indication for gastrointestinal cancer

The FDA on Thursday approved Merck’s anti-PD-1 therapy to treat a type of gastrointestinal cancer in combination with chemotherapy, marking the drug’s 38th indication. The

November 18, 2023

A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids

What’s next for Akeso and Summit Therapeutics after their cancer immunotherapy outperformed Merck’s Keytruda in a large Phase 3 clinical trial? Who’s the iconoclastic outsider

September 12, 2024

Mark Cuban has no doubt he can disrupt health care

If it weren’t for Martin Shkreli, better known as the Pharma Bro, Mark Cuban might not have gone into the drug business. That’s what he

October 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.